You are here

First vaccine made in plant cells receives regulatory approval

Dow AgroSciences announced today it has received the world's first regulatory approval for a plant-made vaccine from USDA's Center for Veterinary Biologics. The company's Concert Plant-Cell-Produced System represents a new category of plant-made vaccines. Instead of using whole plants to produce vaccines, it uses plant cells in a secure, bio-contained environment.

The first product is a vaccine for Newcastle Disease in poultry.

The company says this production system eliminates concerns and challenges associated with making vaccines in whole plants or food crops.

The Concert system uses only the necessary parts of the disease causing agent to stimulate immunity in a manufacturing process that is free from animal components, the company adds.

With this approval, Dow AgroSciences says now it can focus its efforts on developing new vaccines with an emphasis on animal health. Possible target animals include: horses, companion animals (such as dogs and cats), poultry, swine, and cattle.

Using this revolutionary technology for human diseases is "a real possibility" they say.

Learn more at dowagro.com/animalhealth/technology

Dow AgroSciences announced today it has received the world's first regulatory approval for a plant-made vaccine from USDA's Center for Veterinary Biologics. The company's Concert Plant-Cell-Produced System represents a new category of plant-made vaccines. Instead of using whole plants to produce vaccines, it uses plant cells in a secure, bio-contained environment.

Read more about

Talk in Marketing

Most Recent Poll

How much of your 2016 corn crop is planted?